Related Experiment Video

Updated: Apr 6, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.6K

Management of Patients With Stable Angina and Type 2 Diabetes

Prakash C Deedwania1

  • 1University of California, San Francisco, Fresno, CA.

Reviews in Cardiovascular Medicine
|July 23, 2015
PubMed

Insights

Type 2 diabetes (T2D) complicates coronary artery disease (CAD) management. Therapies for stable angina in T2D patients must balance symptom relief with glycometabolic control, prioritizing agents with neutral or positive effects on HbA1c.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Type 2 diabetes (T2D) is a significant risk factor for coronary artery disease (CAD).
  • Patients with comorbid T2D and CAD face increased cardiovascular risks, including silent ischemia and stable angina.
  • Effective management of stable angina in this population requires careful consideration of antianginal therapies' impact on glycemic control.

Purpose of the Study:

  • To review the challenges in treating stable angina in patients with Type 2 diabetes.
  • To highlight the importance of selecting antianginal therapies that do not negatively affect glycemic parameters like HbA1c.
  • To emphasize the need for treatments that offer dual benefits for both stable angina and T2D.

Main Methods:

  • Literature review of available trial data on antianginal agents in patients with stable angina and T2D.
  • Analysis of the impact of common antianginal therapies (e.g., beta-blockers, calcium channel blockers) on glycemic control (HbA1c).
  • Assessment of the potential benefits of therapies with neutral or positive glycometabolic profiles.

Main Results:

  • Limited trial data exist on antianginal agent efficacy in patients with comorbid T2D and stable angina.
  • Some effective antianginal therapies may worsen glycemic control, increasing HbA1c levels.
  • Tailored treatment approaches focusing on glycometabolic profiles are suggested.

Conclusions:

  • Selecting antianginal therapies with neutral or positive glycometabolic profiles is crucial for patients with stable angina and T2D.
  • Dual-acting therapies benefiting both conditions can improve outcomes and reduce polypharmacy.
  • Further prospective studies are needed to guide optimal therapeutic strategies.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
428
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
525
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
627
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
415